Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Health GroupHKSE:00673 24 Days Inventory is 128.87 as of Mar. 2026, which is 193% above its 10-year median of 43.97. GuruFocus rates HKSE:00673 with a GF Score™ of 24/100 and a GF Value™ of HK$0.24 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 117 Medical Distribution companies, China Health Group ranks worse than 82.91% on this metric.
The historical rank and industry rank for China Health Group's Days Inventory or its related term are showing as below:
HKSE:00673'
s Days Inventory Range Over the Past 10 Years
Min: 4.15 Med: 43.97 Max: 197.38
Current: 130.45
During the past 13 years, China Health Group's highest Days Inventory was 197.38. The lowest was 4.15. And the median was 43.97.
HKSE:00673's Days Inventory is ranked worse than 82.91% of 117
companies
in the Medical Distribution industry
Industry Median: 55.31
vs HKSE:00673: 130.45
China Health Group's Days Inventory
declined
from Mar. 2025 (228.24) to Mar. 2026 (128.87).
Inventory Turnover measures how fast the company turns over its inventory within a year.
China Health Group's Inventory Turnover for the
six
months ended in Mar. 2026 was 1.42.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
China Health Group's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.53.
China Health Group (HKSE:00673) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
China Health Group's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
China Health Group's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
China Health Group Days Inventory Related Terms
China Health Group Days Inventory Historical Data
* Premium members only.
The historical data trend for China Health Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00673 vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, China Health Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Group Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China Health Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where China Health Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Group (HKSE:00673) has a Days Inventory of 128.87 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on China Health Group and its competitors. This is 193% above median its historical median of 43.97. Over the past decade, China Health Group's Days Inventory has ranged from 4.15 to 197.38. According to the industry distribution chart, China Health Group ranks #97 out of 117 companies in the Medical Distribution industry, placing it in the top 82.9%.
Is China Health Group's Days Inventory too high?
China Health Group's current Days Inventory of 128.87 is 193% above median its 10-year median of 43.97. Over the past 10 years, this metric has ranged from a low of 4.15 to a high of 197.38. The Medical Distribution industry median Days Inventory is 55.31. China Health Group's value of 128.87 is 133% above this industry median. Based on the distribution chart, China Health Group ranks #97 out of 117 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, China Health Group has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Health Group's Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, China Health Group ranks #97 out of 117 companies for Days Inventory. This places China Health Group in the lower half of its industry. The industry median Days Inventory is 55.31. China Health Group's value of 128.87 is 133% above this benchmark. Historically, China Health Group's own Days Inventory has ranged from 4.15 to 197.38 over the past decade. While the company's 10-year median is 43.97 vs. the industry median of 55.31, China Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 55.31, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Group's current Days Inventory of 128.87 is 133% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on China Health Group and its competitors. For the Medical Distribution industry, the median Days Inventory is 55.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Group's current Days Inventory is 128.87, which is 193% above median its own 10-year median of 43.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Group stock overvalued right now?
Based on GuruFocus' analysis, China Health Group (HKSE:00673) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.24, compared to a current price of HK$0.40 — trading 66.7% above its estimated fair value. The current Days Inventory is 128.87, which is 193% above median its 10-year median of 43.97 and 133% above the Medical Distribution industry median of 55.31. China Health Group's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For China Health Group (HKSE:00673), the current Days Inventory is 128.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Group (HKSE:00673) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Group stock appears to be overvalued.
The current stock price of HK$0.40 is trading 66.7% above its estimated GF Value™ of HK$0.24.
GuruFocus considers China Health Group to be Significantly Overvalued.
Key valuation signals for HKSE:00673:
Days Inventory: 128.87 (193% above median its 10-year median of 43.97)
GF Value™: HK$0.24 vs. price of HK$0.40 (66.7% above fair value)
Industry Position: 133% above the Medical Distribution median (#97 of 117)
No single metric tells the full story. See the HKSE:00673 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Group Ltd is an investment holding company. It is principally engaged in the distribution and service of medical equipment and consumables, provision of hospital operation and management services, and business factoring. It operates in the business in four segments: medical equipment and consumables distribution and service business; hospital operation and management services business; business service; and research and development and sale of functional food. It derives a majority of revenue from the Distribution and service in the medical equipment and consumables segment. Geographically, the group derives its revenue from the PRC.
24GF Score
Get the complete analysis for HKSE:00673
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00673 has been successfully added to your 
